1. Home
  2. GLAS vs PRTA Comparison

GLAS vs PRTA Comparison

Compare GLAS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$1.20

Market Cap

504.2M

Sector

Health Care

ML Signal

N/A

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

N/A

Current Price

$8.19

Market Cap

429.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLAS
PRTA
Founded
2015
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.2M
429.2M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
GLAS
PRTA
Price
$1.20
$8.19
Analyst Decision
Strong Buy
Buy
Analyst Count
3
7
Target Price
$6.67
★ $21.40
AVG Volume (30 Days)
★ 2.2M
420.1K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $814,000.00
Revenue This Year
$0.52
$775.41
Revenue Next Year
$20.48
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.06
$7.70
52 Week High
$12.70
$11.80

Technical Indicators

Market Signals
Indicator
GLAS
PRTA
Relative Strength Index (RSI) 23.92 45.39
Support Level $1.06 $8.01
Resistance Level $2.81 $9.20
Average True Range (ATR) 0.29 0.44
MACD 0.08 -0.01
Stochastic Oscillator 6.50 34.93

Price Performance

Historical Comparison
GLAS
PRTA

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: